114 related articles for article (PubMed ID: 2864316)
1. Pharmacological characterization of mouse ear PCA.
Inagaki N; Goto S; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1985; 78(2):113-7. PubMed ID: 2864316
[TBL] [Abstract][Full Text] [Related]
2. A method for evaluating anti-allergic drugs by simultaneously induced passive cutaneous anaphylaxis and mediator cutaneous reactions.
Koda A; Miura T; Inagaki N; Sakamoto O; Arimura A; Nagai H; Mori H
Int Arch Allergy Appl Immunol; 1990; 92(3):209-16. PubMed ID: 1703513
[TBL] [Abstract][Full Text] [Related]
3. Effects of different drugs on passive cutaneous anaphylaxis elicited in the mouse ear at 1.5 hours.
Inagaki N; Nagai H; Xu QA; Daikoku M; Nakatomi I; Koda A
Int Arch Allergy Appl Immunol; 1988; 86(2):157-61. PubMed ID: 2455688
[TBL] [Abstract][Full Text] [Related]
4. Studies on vascular permeability increasing factors involved in 48-hour homologous PCA in the mouse ear.
Inagaki N; Goto S; Yamasaki M; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1986; 80(3):285-90. PubMed ID: 3087885
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of passive cutaneous anaphylaxis (PCA) by azelastine: dissociation of its antiallergic activities from antihistaminic and antiserotonin properties.
Chand N; Harrison JE; Rooney SM; Sofia RD; Diamantis W
Int J Immunopharmacol; 1985; 7(6):833-8. PubMed ID: 3935586
[TBL] [Abstract][Full Text] [Related]
6. Mouse ear PCA as a model for evaluating antianaphylactic agents.
Inagaki N; Goto S; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1984; 74(1):91-2. PubMed ID: 6706427
[TBL] [Abstract][Full Text] [Related]
7. Active cutaneous anaphylaxis (ACA) in the mouse ear.
Inagaki N; Miura T; Nagai H; Koda A
Jpn J Pharmacol; 1992 Jun; 59(2):201-8. PubMed ID: 1434116
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.
Inagaki N; Miura T; Daikoku M; Nagai H; Koda A
Pharmacology; 1989; 39(1):19-27. PubMed ID: 2479953
[TBL] [Abstract][Full Text] [Related]
9. Effects of antiallergic drugs on bronchial and cutaneous anaphylaxis in Lewis rats.
Misawa M; Takenouchi K; Kamishiro T; Yoshino Y; Yanaura S
J Pharmacobiodyn; 1988 Feb; 11(2):74-9. PubMed ID: 2454312
[TBL] [Abstract][Full Text] [Related]
10. Homologous passive cutaneous anaphylaxis (PCA) in mice and heterologous PCA induced in rats with mouse IgE.
Braga F; Mota I
Immunology; 1976 May; 30(5):655-69. PubMed ID: 179937
[TBL] [Abstract][Full Text] [Related]
11. Anti-allergic effects of ketanserin on animal models of allergic reactions.
Nagai H; Suda H; Kitagaki K; Goto S; Miura T; Koda A
Arch Int Pharmacodyn Ther; 1990; 307():172-82. PubMed ID: 1710442
[TBL] [Abstract][Full Text] [Related]
12. Passive air-pouch anaphylaxis in rats. II. Pharmacological characterization.
Konno-Amano S; Hirao T; Kohno H; Mori H; Sato Y
Int Arch Allergy Appl Immunol; 1989; 90(4):338-44. PubMed ID: 2482256
[TBL] [Abstract][Full Text] [Related]
13. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
Terasawa M; Imayoshi T; Goto K
Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):93-101. PubMed ID: 6194083
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of the release of slow-reacting substance of anaphylaxis in the rat with diethylcarbamazine.
Orange RP; Valentine MD; Austen KF
Proc Soc Exp Biol Med; 1968 Jan; 127(1):127-32. PubMed ID: 4384569
[No Abstract] [Full Text] [Related]
16. Susceptibility of four types of cutaneous anaphylaxis in the mouse to antihistaminics.
Harada M; Takeuchi M; Katagiri K
Int Arch Allergy Appl Immunol; 1968; 34(4):409-16. PubMed ID: 4386788
[No Abstract] [Full Text] [Related]
17. [Inhibitory effect on the release of mediators from rat peritoneal exudate cells and the antagonistic effect against mediators of MY-5116 and other anti-allergic agents].
Yamada N; Takahashi K; Endoh K; Arai Y
Nihon Yakurigaku Zasshi; 1986 Sep; 88(3):229-37. PubMed ID: 2431983
[TBL] [Abstract][Full Text] [Related]
18. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
Yamamura H; Kohno S; Ohata K
Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of passive cutaneous anaphylaxis by several histamine (H1) and serotonin antagonists in the rat.
Metys J; Frycová H; Soucek R
Agents Actions; 1988 Apr; 23(3-4):331-3. PubMed ID: 3394585
[TBL] [Abstract][Full Text] [Related]
20. Antiallergic mechanisms of beta-adrenergic stimulants in rats.
Inagaki N; Miura T; Nagai H; Koda A
Life Sci; 1992; 51(21):PL201-5. PubMed ID: 1279338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
